FAQ’s

Mycelium Enterprises is the best single source of products and services needed for the growing and cultivation of edible gourmet and functional/medicinal mushrooms. Mycelium Enterprises is positioned to be a leading supplier of the total infrastructure requirements and services to individuals and commercial operations looking for a single source for the thriving mushroom sector.  

Mycelium Enterprises has created a series of patentable products and processes that offer an extensive array of turnkey cultivation solutions including sterilizers, grains, substrates, laboratory equipment, and storage. We also provide advisory services from accomplished Mycologists.

Mycelium Enterprises is focused on being in the forefront of new processes and growing techniques so that more people can harness the incredible healing powers of the fungi world.

The legislation today for the magic mushroom/psilocybin sector is similar to when the first cannabis licenses were approved for medical use in California in 1996. It must be noted that the most successful ventures in cannabis have been the infrastructure, services, and consumable providers. Groups such as Vitalis Extraction Systems, Cascade Sciences, Hawthorne Gardens, and various others have been able to generate significant revenue and cash flow as commercial cannabis production capacity has been developed. After looking at these industries develop and flourish, we have developed our picks and shovel approach to mirror their success.  

Mycelium encompasses not only a picks and shovel strategy approach to creating turnkey solutions for the ever-thriving mushroom industry, but also has its goals set on working towards having the most premier genetics in the field. We also plan on being a world provider of edible gourmet and functional/medicinal fruiting bodies and extracts as we expand our cultivation footprint across the nation in 2024. 

Mycelium’s pathway to revenue is to utilize our exclusive state of the art large-scale sterilization technology to create our line of sterile grains and substrates and become the mecca for all things mushrooms. The company’s direct to consumer website, as well as our Amazon and other affiliate distribution channels will drive our online B2B and B2C revenues. The production facility will showcase first-of-its-kind engineered turnkey solutions for growing mushrooms on a commercial scale.

Mycelium is developing many of its own products and proprietary processes, focusing on being a key supplier of the high-volume consumables that are needed by every grower/cultivator. Mycelium will provide turnkey solutions that include key ingredients, processing equipment, and hygienic lab supplies at scale. This allows us to provide cost-effective solutions while maintaining healthy margins, with the following divisions: 

• Grains & Substrates (Dry & Sterile) 
• Metals Division 
• Plastic Division 
• Growing Containers 
• Lab Equipment 
• Training Programs 
• Complete Grow Kits 
• Sterilization Equipment 

The Mycelium model is simple: Mycelium aims to corner the mushroom industry by employing a picks and shovel strategy rather than focusing on a sole aspect of production.    

Mycelium sells products and services needed for the growing and cultivation of edible gourmet and functional/medicinal mushrooms.  

By focusing on the technology needed to produce a wide range of mushroom products – rather than only the final output – we leverage our knowledge and IP by mitigating the risks associated with only focusing on cultivation. 

The pick-and-shovel strategy is a proven approach with recent successful examples from the new emerged cannabis industry. 

Proof-of-Concept 

GrowGeneration
GrowGeneration is the nation’s largest chain of specialty hydroponic and organic garden centers with 39 locations across 11 states. Reported preliminary record full-year 2020 revenue of $192 million versus $80M for 2019, an increase of 140%. As the company continues to outpace guidance, it is increasing its 2021 revenue guidance range to $335 – 350 million. 

Hawthorne, subsidiary of Scott Miracle Grow
The hydroponic subsidiary of Scott Miracle grow, Hawthorne Gardening Co., topped $1B, up 61% from the prior year, driven mainly by supplying the marijuana industry with equipment such as lights and greenhouse fans. NYSE: SMG 

By keeping these previously listed companies’ approaches in mind, we plan to steer Mycelium into a successful future. 

The total available market size for functional mushrooms is estimated to be $34B. 

$34B is one small slice of the massive Global Wellness Market, which is estimated to be $42T.  

The growing food and beverage industry, along with the rising health consciousness among consumers across the globe, is one of the key factors driving growth.   

Owing to shifting dietary preferences toward vegan and vegetarian foods, mushrooms are being preferred as a protein, vitamin, and mineral-rich substitute of meat.  

Widespread product adoption by the pharmaceutical industry is also providing a boost to the market growth. Mushrooms consist of compounds that aid in the treatment of diseases, such as hypercholesterolemia and hypertension.  

Mushrooms also have anti-inflammatory, antioxidant, and anti-carcinogenic properties, which are extensively used in manufacturing medicines.  

The cannabis industry has been plagued by a slew of political and regulatory challenges at the local, state, and federal level. However, the mushroom industry enjoys different market dynamics that are helping to expedite commercialization. 
 
Rather than grassroots political efforts as in the case of cannabis, the legal environment for psychedelics is much more transparent. With the mushroom industry being driven by scientific and academic research seeking regulatory approvals, psychedelics, as well as nutraceuticals and pharmaceutical products,  are able to make medical claims. FDA approved trials have been done by various esteemed institutions such as Johns Hopkins, leading the way for an entirely new field of medicine.  

1. How mushrooms took over food, wellness, and (of course) drugs. – https://www.vox.com/the-goods/22372504/mushrooms-food-wellness-drugs

2. The Mycelium Resolution is Upon Us – https://blogs.scientificamerican.com/observations/the-mycelium-revolution-is-upon-us/

3. Why investors are turning toward psychedelic health care companies – https://fortune.com/2021/09/04/psychedelic-industry-investment-growth-stocks-companies/

4. Why Investing in Psychedelic Medicine Could Be Better Than Cannabis – https://money.usnews.com/investing/articles/why-investing-in-psychedelic-medicine-could-be-better-than-cannabis

5. Denver pursues further decriminalization of magic mushrooms – https://www.axios.com/local/denver/2021/04/13/denver-magic-mushrooms-decriminalization-psilocybin

6. Adidas’ Stan Smith Mylo are its first mushroom leather sneakers – https://www.engadget.com/adidas-mylo-mycelium-mushroom-leather-stan-smith-future-of-leather-130021186.html

7. Psychedelic therapies show promise. Is California ready to bring them into the mainstream? – https://calmatters.org/health/2023/08/california-decriminalize-psychedelic-mushrooms/

• Significant demand already exists. 
• Supply chain is inefficient, fragmented, and can be improved. 
• Branding and product innovation will drive differentiation. 
• Opportunity to scale vertically and across channels.  

• Visit our contact us page
• Reach us by phone – (657) 251-0016 
• Visit one of our locations – 10632 Trask Avenue, Garden Grove, CA 92843 
• Visit our booths at tradeshows 

Garden Grove Location – 9am – 5pm PST 
10632 Trask Avenue
Garden Grove, CA 92843